American Health Packaging Recalls Chlorpromazine Tablets Over Contamination Risk
American Health Packaging recalled 1,757 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a microorganism in packaging materials, though no contamination was found on the tablets themselves. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Hazard Information
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter
Product Details
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 100 mg, packaged in 100 (10x10) blister packs per carton. The affected lot numbers include 1021652, 1022539, and 1023666, with expiration dates ranging from January 31, 2027, to March 31, 2027.
The Hazard
The recall involves the presence of a microorganism detected in auxiliary polyester coil packaging. This poses a risk to consumers, although the tablets themselves tested negative for contamination.
Reported Incidents
No injuries or incidents have been reported related to this contamination. The recall is classified as Class II due to the potential risk associated with the packaging.
What to Do
Consumers should stop using the recalled Chlorpromazine Hydrochloride Tablets immediately. They can contact Amerisource Health Services LLC or their healthcare provider for further guidance.
Contact Information
For more information, consumers can visit the FDA's recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0649-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.